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The aim of this data article is to provide data for a basic knowledge of
the properties of lipid nanocapsules, a new colloidal system with very
promising applications in drug delivery. Firstly, we pay attention on
how it is possible to determine their surface composition by means of
electrokinetics measurements. On the other hand, we provide
experimental evidences for a better understanding of the factors that
determine the interactions of these nanoparticles with cells as a
necessary step to guide the design of the most effective formulations.
Additionally, we supply information about encapsulation efﬁciency of
docetaxel, a potent chemotherapy drug, inside nanocapsules support-
ing the experimental cytotoxicity results of these nanosystems.
& 2015 The Authors. Published by Elsevier Inc. This is an open access
article under the CC BY license
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P. Sánchez-Moreno et al. / Data in Brief 4 (2015) 279–2842801. Speciﬁcations tableSubject area Materials Science, Physics, Biology
More speciﬁc
subject areaNanotechnology, Development of drug delivery nanosystemsType of data Text and graphs
How data was
acquiredDynamic light-scattering. Flow cytometry. High performance liquid chromatography (HPLC).Data format Analyzed
Experimental factors Lipid nanocapsules obtained by solvent displacement technique with a core of olive oil and a shell
composed by lecithin, poloxamers or their mixtures.
The human lung-cancer cell line (A549) and the human leukemic monocytic lymphoma cell line (U937)Experimental
featuresElectrophoretic mobility measurements. Uptake analysis of Coumarin 6-loaded nanocapsules.
Determination of the encapsulation efﬁciency of Docetaxel.Data source location Dpt. of Applied Physics, Faculty of Science, University of Granada, Granada, Spain.
Data accessibility Data are available within this article and are related to [1]2. Value of the data Electrophoretic mobility data of different lipidic nanocapsules with different surface composition
allow the determination of the shell composition of these nanosystems. Data from experiments of cell uptake using two different cell lines in both serum free and
complete medium conditions, will let other researchers to know that the nature of interactions of
the same material in the presence or absence of proteins differs. The cytotoxicity experiments show how the dosage of docetaxel necessary to induce the same
cytotoxic effect in cancer cells that free docetaxel is much lesser in loaded-nanocapsules.
3. Data, experimental design, materials and methods
In the following sections we will present a detailed description about how to synthesize some
lipidic nanocapsules with potential applications as antitumor-drug delivery carriers. As demonstrated,
it is possible to get valuable information about the nature of their surfaces by means of electrophoretic
mobility measurements. Subsequently, once these particles are incubated with different cancer-cell
lines in presence or absence of proteins, it is demonstrated a correlation between different cellular
uptake patterns observed and the different nature existing in the particle surfaces. Finally, an analysis
of the drug (docetaxel) release combined with a study of cytotoxicity is also shown.3.1. Material preparation
Different lipidic nanocapsule systems with the same olive oil core and shells of different
composition and different surface properties were prepared using two surfactants with a markedly
different nature, a non-ionic poloxamer and a charged phospholipid. The synthesis procedure was
based on an emulsion solvent extraction technique previously reported [1,2]. In this way, the shell of
the EP nanocapsules was exclusively composed by phospholipids (lecithin); in the case of the ME
nanocapsules was composed by a mixture of lecithin and poloxamer with a predominance of the ﬁrst
one; for the MP nanocapsules both surfactants were present in the shell with a predominance of
poloxamer; and ﬁnally, the PL nanocapsules with the shell exclusively composed by poloxamer.
Docetaxel-loaded lipid nanocapsules were formulated in the same way by dissolving docetaxel in the
olive oil phase at a concentration of 0.1% (w/w), while Coumarin 6 lipid nanocapsules were formulated
dissolving the dye in the olive oil phase at a concentration of 0.025% (w/w).
































Fig. 1. Electrophoretic mobility vs. pH in buffered media of low salinity (ionic strength equal to 0.002 M) for different
nanosystems. (○) EP nanocapsules exclusively composed by lecithin (2.22 mg/ml); (Δ) ME nanocapsules composed by a
mixture of lecithin (2.22 mg/ml) and poloxamer (0.39 mg/ml) with a predominance of the ﬁrst one; (◊) MP nanocapsules with
both surfactants, lecithin (0.22 mg/ml) and poloxamer (3.89 mg/ml) with a predominance of this last; and (□) PL nanocapsules,
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Fig. 2. Uptake of ME (A), MP (B) and PL (C) lipid nanocapsules in SF (horizontal gray lines) and cDMEM medium (horizontal
lines) by A549 cells as determined by ﬂow cytometry. Error bars are the standard deviation of the mean cell ﬂuorescence
intensity averaged over 3 replicates. For all the types of nanocapsules, the uptake in SF was higher than in complete medium.
Cells exposed to several types of particles for up to 24 h, changed their phenotype and lost cell adhesion, which is indicative of
cell damage, due to the strong adhesion of bare nanoparticle surfaces to the cell membrane. In fact, we could not determine the
uptake by ﬂow cytometry of EP nanoparticles in SF because they seriously damaged cells already after short exposure times.
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Electrophoretic mobility, μe, was measured by Dynamic light-scattering (Zeta-Sizer NanoZ, Malvern
Instruments, UK) after pouring a small volume of the nanocapsule stock (with a total surface area equal to
0.05 m2) into 1 mL of a low salinity solution (0.002 M) containing the buffer with the desired pH value
ranging from 3 to 9. μe is an electrokinetic experimental parameter dependent of the surface electrical
potential, which is ultimately governed by the composition of the lipid nanocapsules surface and by the
salinity and pH conditions of the medium in which the particles are dispersed (Fig. 1).3.3. Data on cellular uptake under different conditions
The U937 human leukemic monocytic lymphoma cell line (1.5105 cells), previously activated to
macrophages with phorbol 12-myristate 13-acetate (PMA) for 48 h, and the A549 human lung-cancer
cell line (1.5105 cells) were seeded into 6-well plates in complete culture medium (cDMEM). After
24 h, before exposure to nanoparticles, the cDMEM was removed; then, cells were washed once with
PBS buffer prior to the addition of the nanoparticle dispersions. Coumarin 6-loaded nanocapsule
dispersions were prepared by diluting the nanoparticle stock to the required concentration in SF or
cDMEM just before addition to cells. In the control groups, cells were treated with non-ﬂuorescent
nanocarriers. After cell incubation, cells were washed three times with phosphate-buffered saline
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Fig. 3. Uptake of ME (A), MP (B) and PL (C) lipid nanocapsules in SF (horizontal gray lines) and cDMEM medium (horizontal
lines) by macrophages as determined by ﬂow cytometry. For all the types of nanocapsules, the uptake in SF was higher than in
complete medium.
P. Sánchez-Moreno et al. / Data in Brief 4 (2015) 279–284 283EDTA) and pelleted by centrifugation. Then, they were ﬁxed at room temperature with a 4% formalin
solution for 20 min and re-suspended in PBS before measuring the cell-associated ﬂuorescence
(15,000 cells per sample) using a FacsCalibur ﬂow cytometry device (Becton Dickinson). The results
are represented by averaging the distribution of cell ﬂuorescence intensity, working with three
independent replicates. Error bars represent the standard deviation between replicates. Each
experiment was performed at least three times.
These experiments determined the effect of the surface properties of different nanocapsules
systems on the interaction with the A549 human lung-cancer cell line (Fig. 2) and the U937 human
leukemic monocytic lymphoma cell line (Fig. 3) in serum free (SF) and complete medium (cDMEM)





























Fig. 4. Concentration of docetaxel encapsulated in the four different nanocapsules after 1, 3, 5, 12 and 24 h of dialysis in water
to remove the unbound surfactant molecules. After ﬁve hours of dialysis the 20% of docetaxel added in the synthesis remained
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Fig. 5. Cytotoxicity curves at different concentrations of free docetaxel and docetaxel loaded nanocapsules. Curves show that all
docetaxel loaded-nanoparticles signiﬁcantly decreased cell viability at low concentrations in comparison to cells treated with
free docetaxel. These results indicate that the treatment with docetaxel-loaded nanocapsules allow a substantial decrease in the
dosage of the drug.
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The docetaxel encapsulation efﬁciency was calculated by HPLC at the Scientiﬁc Instrumentation
Center of the University of Granada, using a SHIMADZU LC-20AC chromatograph with SPD-M20A
diode array detector and C8 Nova-Pak Cartridge column (4 μm, 4.6150 mm). Detection was
performed at a wavelength of 230 nm (Fig. 4). Finally, to obtain the cytotoxicity curves, A549 cells
(2104) were plated into 24-well plates with fresh cDMEM and increased concentrations of free and
encapsulated docetaxel for 48 h. Then, cells were counted using the sulforhodamine-B (SRB)
colorimetric assay in a Titertek Multiscan apparatus (Flow, Irvine, CA, USA) at 492 nm (Fig. 5).Acknowledgments
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